Adenovirus_NN Type_NP 11_CD Uses_NP CD46_NP as_IN a_DT Cellular_NP Receptor_NP The_DT 51_CD human_JJ adenovirus_NN serotypes_NNS are_VBP divided_VBN into_IN six_CD species_NNS (_( A_DT to_TO F_NP )_) ._SENT Many_JJ adenoviruses_NNS use_VBP the_DT coxsackie-adenovirus_NN receptor_NN (_( CAR_NN )_) for_IN attachment_NN to_TO host_VB cells_NNS in_IN vitro_NN ._SENT Species_NP B_NP adenoviruses_NNS do_VBP not_RB compete_VB with_IN CAR-binding_JJ serotypes_NNS for_IN binding_VBG to_TO host_NN cells_NNS ,_, and_CC it_PP has_VBZ been_VBN suggested_VBN that_IN species_NN B_NN adenoviruses_NNS use_VBP a_DT receptor_NN other_JJ than_IN CAR_NP ._SENT Species_NP B_NP adenoviruses_NNS mainly_RB cause_VBP disease_NN in_IN the_DT respiratory_JJ tract_NN ,_, the_DT eyes_NNS ,_, and_CC in_IN the_DT urinary_JJ tract_NN ._SENT Here_RB we_PP demonstrate_VBP that_IN adenovirus_NN type_NN 11_CD (_( Ad11_NP ;_: of_IN species_NN B_NN )_) binds_NNS to_TO Chinese_JJ hamster_NN ovary_NN (_( CHO_NP )_) cells_NNS transfected_VBN with_IN CD46_NP (_( membrane_NN cofactor_NN protein)-cDNA_NN at_IN least_JJS 10_CD times_NNS more_RBR strongly_RB than_IN to_TO CHO_NP cells_NNS transfected_VBN with_IN cDNAs_NNS encoding_VBG CAR_NP or_CC CD55_NP (_( decay_VB accelerating_VBG factor_NN )_) ._SENT Nonpermissive_JJ CHO_NP cells_NNS were_VBD rendered_VBN permissive_JJ to_TO Ad11_JJ infection_NN upon_IN transfection_NN with_IN CD46-cDNA_NP ._SENT Soluble_JJ Ad11_JJ fiber_NN knob_NN but_CC not_RB Ad7_JJ or_CC Ad5_JJ knob_NN inhibited_VBD binding_VBG of_IN Ad11_JJ virions_NNS to_TO CD46-transfected_JJ cells_NNS ,_, and_CC anti-CD46_NN antibodies_NNS inhibited_VBD both_DT binding_NN of_IN and_CC infection_NN by_IN Ad11_NP ._SENT From_IN these_DT results_NNS we_PP conclude_VBP that_IN CD46_NP is_VBZ a_DT cellular_JJ receptor_NN for_IN Ad11_NP ._SENT The_DT adenovirus_NN family_NN contains_VBZ 51_CD human_JJ serotypes_NNS ,_, which_WDT are_VBP divided_VBN into_IN six_CD species_NNS designated_VBN A_NP through_IN F_NP ._SENT Most_RBS human_JJ adenoviruses_NNS cause_VBP disease_NN in_IN the_DT respiratory_JJ tract_NN ,_, kidney_NN ,_, eyes_NNS ,_, intestine_NN ,_, or_CC lymphoid_JJ tissue_NN ._SENT The_DT antigenic_JJ determinants_NNS on_IN the_DT outer_JJ parts_NNS of_IN the_DT capsid_NN are_VBP mainly_RB contributed_VBN by_IN three_CD polypeptides_NNS :_: the_DT hexon_NN ,_, the_DT penton_NN base_NN ,_, and_CC the_DT fiber_NN ._SENT The_DT hexon_NN protein_NN is_VBZ the_DT major_JJ constituent_NN of_IN the_DT particle_NN ,_, and_CC each_DT of_IN the_DT 12_CD vertices_NN carries_VBZ a_DT pentameric_JJ penton_NN base_NN protein_NN bearing_VBG one_CD trimeric_JJ fiber_NN protein_NN ._SENT The_DT knob_NN domain_NN of_IN the_DT viral_JJ fiber_NN protein_NN has_VBZ been_VBN shown_VBN to_TO mediate_VB attachment_NN to_TO host_VB cells_NNS in_IN vitro_NN ,_, whereas_IN the_DT penton_NN base_NN facilitates_VBZ the_DT subsequent_JJ internalization_NN step_NN ._SENT Adenovirus_NN type_NN 2_CD (_( Ad2_NP )_) and_CC Ad5_NP (_( both_CC of_IN species_NN C_NP )_) have_VBP been_VBN the_DT best_RBS characterized_VBN with_IN respect_NN to_TO host_VB cell_NN interactions_NNS and_CC both_DT have_VBP been_VBN demonstrated_VBN to_TO utilize_VB the_DT coxsackie-adenovirus_NN receptor_NN (_( CAR_NN )_) for_IN binding_VBG and_CC infection_NN of_IN host_NN cells_NNS in_IN vitro_NN ._SENT In_IN addition_NN ,_, adenovirus_NN members_NNS from_IN species_NN A_NP ,_, D_NP ,_, E_NP ,_, and_CC F_NP have_VBP been_VBN demonstrated_VBN to_TO interact_VB with_IN soluble_JJ CAR_NN in_IN vitro_NN ._SENT The_DT CAR-binding_NP site_NN is_VBZ conserved_VBN on_IN CAR-binding_NP fibers_NNS and_CC has_VBZ been_VBN localized_VBN to_TO the_DT AB-loop_NN in_IN the_DT knob_NN domain_NN ._SENT CAR_NN belongs_VBZ to_TO the_DT immunoglobulin_NN superfamily_NN and_CC has_VBZ been_VBN shown_VBN to_TO immunoprecipitate_VB ,_, together_RB with_IN both_DT ZO-1_NP and_CC beta-catenin_NP ,_, which_WDT are_VBP components_NNS of_IN tight_JJ and_CC adhesion_NN junctions_NNS ,_, respectively_RB ._SENT Moreover_RB ,_, CAR_NP is_VBZ capable_JJ of_IN forming_VBG intercellular_JJ homodimers_NNS and_CC appears_VBZ to_TO be_VB an_DT important_JJ component_NN in_IN contacts_NNS between_IN epithelial_JJ cells_NNS ._SENT CAR_NN is_VBZ also_RB expressed_VBN basolaterally_RB in_IN well-differentiated_JJ airway_NN epithelium_NN but_CC not_RB apically_RB ._SENT Thus_RB ,_, CAR_NP is_VBZ not_RB easily_RB accessible_JJ for_IN adenoviruses_NNS ,_, and_CC it_PP has_VBZ been_VBN suggested_VBN that_IN transient_JJ breaks_NNS in_IN the_DT epithelium_NN may_MD be_VB required_VBN in_IN order_NN for_IN adenoviruses_NNS to_TO infect_VB host_NN cells_NNS via_IN CAR_NN ._SENT Recently_RB ,_, a_DT novel_JJ function_NN for_IN adenovirus-CAR_NN interactions_NNS was_VBD described_VBN ._SENT Before_IN lysis_NN of_IN the_DT infected_JJ cells_NNS ,_, an_DT excess_NN of_IN virus_NN fibers_NNS is_VBZ produced_VBN ,_, and_CC these_DT are_VBP secreted_VBN basolaterally_RB ._SENT Since_IN the_DT affinity_NN of_IN CAR-fiber_NP interactions_NNS is_VBZ greater_JJR than_IN that_IN of_IN of_IN CAR-CAR_NN interactions_NNS ,_, fibers_NNS disrupt_VBP intercellular_JJ CAR_NN dimers_NNS ,_, increase_VB intercellular_JJ space_NN ,_, and_CC allow_VB complete_JJ particles_NNS to_TO filter_VB from_IN the_DT basolateral_JJ side_NN and_CC escape_VB apically_RB ._SENT Consequently_RB ,_, a_DT main_JJ function_NN of_IN fiber-CAR_NN interactions_NNS may_MD be_VB to_TO facilitate_VB prelytic_JJ viral_JJ escape_NN ._SENT Species_NP D_NP contains_VBZ 32_CD different_JJ serotypes_NNS ,_, but_CC most_JJS of_IN these_DT serotypes_NNS are_VBP rarely_RB isolated_VBN from_IN humans_NNS ._SENT However_RB ,_, three_CD serotypes_NNS (_( Ad8_NP ,_, Ad19_NP ,_, and_CC Ad37_JJ )_) cause_VB a_DT severe_JJ ocular_JJ disease_NN designated_VBN epidemic_JJ keratoconjunctivitis_NN ._SENT We_PP have_VBP recently_RB shown_VBN that_IN these_DT three_CD viruses_NNS use_VBP sialic_JJ acid_NN as_IN cellular_JJ receptors_NNS instead_RB of_IN CAR_NN and_CC that_IN ,_, in_IN these_DT serotypes_NNS ,_, the_DT affinity_NN of_IN the_DT fiber_NN for_IN sialic_JJ acid_NN is_VBZ mediated_VBN by_IN a_DT charge-dependent_JJ interaction_NN between_IN the_DT unusually_RB positively_RB charged_VBN fiber_NN knobs_NNS of_IN these_DT viruses_NNS (_( pI_NN 9_CD to_TO 9.1_CD )_) and_CC sialic_JJ acid_NN (_( pKa_NP 2.6_CD )_) ._SENT We_PP have_VBP also_RB shown_VBN that_IN the_DT sialic_JJ acid_JJ receptor_NN sacharrides_NNS are_VBP linked_VBN to_TO membrane_NN proteins_NNS rather_RB than_IN to_TO lipids_NNS ,_, but_CC the_DT identity_NN of_IN the_DT sialylated_JJ protein(s)_NN is_VBZ still_RB unknown_JJ ._SENT Recently_RB ,_, and_CC contrary_JJ to_TO our_PP$ own_JJ findings_NNS ,_, E._NP Wu_NP et_FW al._FW suggested_VBD that_IN Ad37_NP attaches_VBZ to_TO cells_NNS via_IN a_DT 50-kDa_NP membrane_NN protein_NN independently_RB of_IN sialic_JJ acid_NN and_CC that_IN this_DT interaction_NN is_VBZ dependent_JJ on_IN divalent_JJ cations_NNS ._SENT In_IN contrast_NN to_TO the_DT results_NNS of_IN these_DT workers_NNS ,_, we_PP found_VBD that_IN the_DT attachment_NN of_IN Ad37_JJ to_TO Chang_NP C_NP cells_NNS ,_, and_CC thus_RB infection_NN ,_, is_VBZ entirely_RB dependent_JJ on_IN sialic_JJ acid_NN but_CC independent_JJ of_IN divalent_JJ cations_NNS ._SENT Species_NP B_NP adenoviruses_NNS have_VBP been_VBN subdivided_VBN into_IN B:1_NP (_( Ad3_NP ,_, Ad7_NP ,_, Ad16_NP ,_, Ad21_NP ,_, and_CC Ad50_NP )_) and_CC B:2_NP (_( Ad11_NP ,_, Ad14_NP ,_, Ad34_NP ,_, and_CC Ad35_NP )_) ._SENT Within_IN species_NN B_NP ,_, Ad3_NP and_CC Ad7_NP are_VBP among_IN the_DT most_RBS commonly_RB isolated_VBN viruses_NNS ._SENT Several_JJ species_NN B_NN adenoviruses_NNS cause_VBP respiratory_JJ and_CC ocular_JJ infections_NNS ._SENT In_IN addition_NN ,_, species_NNS B:2_NP viruses_NNS ,_, other_JJ than_IN Ad14_NP ,_, cause_NN infections_NNS of_IN the_DT kidney_NN and/or_CC urinary_JJ tract_NN ._SENT Species_NP B_NP adenoviruses_NNS do_VBP not_RB compete_VB with_IN species_NNS C_NP adenoviruses_NNS for_IN binding_VBG to_TO CAR_NNS and_CC do_VBP not_RB bind_VB to_TO CAR_NN in_IN vitro_NN ._SENT We_PP reported_VBD recently_RB that_IN two_CD different_JJ species_NNS B:2_NP adenoviruses_NNS (_( Ad11_NP and_CC Ad35_NP )_) could_MD block_VB the_DT binding_NN of_IN two_CD different_JJ B:1_JJ viruses_NNS (_( Ad3_NP and_CC Ad7_JJ )_) to_TO host_VB cells_NNS but_CC that_IN the_DT B:1_NP viruses_NNS were_VBD unable_JJ to_TO block_VB binding_VBG of_IN the_DT B:2_NP viruses_NNS ._SENT Moreover_RB ,_, the_DT binding_NN of_IN B:1_NP ,_, but_CC not_RB B:2_NP ,_, viruses_NNS was_VBD dependent_JJ on_IN divalent_JJ cations_NNS and_CC sensitive_JJ to_TO prior_JJ trypsination_NN of_IN host_NN cells_NNS ._SENT Based_VBN on_IN these_DT findings_NNS ,_, we_PP suggested_VBD that_IN adenoviruses_NNS from_IN species_NNS B:1_NP and_CC B:2_NP interact_VBP with_IN a_DT cellular_JJ receptor_NN designated_VBN sBAR_NP (_( species_NN B_NP adenovirus_NN receptor_NN )_) ._SENT In_IN addition_NN ,_, the_DT species_NNS B:2_NP adenoviruses_NNS Ad11_NP and_CC Ad35_NP were_VBD suggested_VBN to_TO interact_VB with_IN an_DT additional_JJ receptor_NN designated_VBN sB2AR_NP (_( species_NN B:2_NP adenovirus_NN receptor_NN )_) ._SENT Adenoviruses_NNS in_IN general_JJ have_VBP many_JJ receptor-binding_NN characteristics_NNS in_IN common_JJ with_IN picornaviruses_NNS ,_, including_VBG the_DT ability_NN to_TO use_VB CAR_JJ ,_, sialic_JJ acid_NN ,_, VCAM-1_NP ,_, heparan_JJ sulfate_NN ,_, MHC-1_NP ,_, and_CC alphav_NN integrins_NNS as_IN receptors_NNS or_CC coreceptors_NNS ._SENT Several_JJ picornaviruses_NNS are_VBP also_RB capable_JJ of_IN using_VBG decay_NN accelerating_VBG factor_NN (_( DAF_NP ;_: CD55_NP )_) as_IN a_DT cellular_JJ receptor_NN ._SENT CD55_NP and_CC CD46_NP (_( membrane_NN cofactor_JJ protein_NN [_SYM MCP_NP ]_SYM )_) are_VBP two_CD closely_RB related_VBN members_NNS of_IN the_DT complement_NN system_NN ._SENT CD55_NP regulates_VBZ the_DT activity_NN of_IN C3_NP convertases_NNS ,_, whereas_IN CD55_NP acts_NNS as_IN a_DT cofactor_NN for_IN factor_NN 1-mediated_JJ cleavage_NN of_IN C3b_NP and_CC C4b_NP protein_NN ._SENT CD55_NP has_VBZ been_VBN suggested_VBN to_TO associate_VB directly_RB with_IN CAR_NN ,_, and_CC even_RB if_IN CD55_NP is_VBZ not_RB used_VBN as_IN an_DT adenovirus_NN receptor_NN ,_, monoclonal_NN anti-CD55_NN antibodies_NNS partially_RB inhibit_VBP Ad2_NP binding_VBG to_TO HeLa_NP cells_NNS ,_, indicating_VBG that_IN many_JJ adenoviruses_NNS attach_VBP to_TO host_VB cells_NNS in_IN close_JJ proximity_NN to_TO CD55_NP ._SENT Both_DT CD55_NP and_CC CD46_NP are_VBP expressed_VBN on_IN most_JJS cells_NNS throughout_IN the_DT body_NN ._SENT However_RB ,_, CD46_NP is_VBZ expressed_VBN on_IN monkey_NN erythrocytes_NNS but_CC not_RB on_IN human_JJ erythrocytes_NNS ,_, whereas_IN CD55_NP is_VBZ expressed_VBN on_IN both_DT human_JJ and_CC monkey_NN erythrocytes_NNS ._SENT This_DT is_VBZ of_IN interest_NN ,_, since_IN it_PP has_VBZ been_VBN shown_VBN that_IN species_NN B_NN adenoviruses_NNS agglutinate_VBP erythrocytes_NNS from_IN monkeys_NNS but_CC not_RB from_IN humans_NNS ._SENT With_IN this_DT in_IN mind_NN ,_, we_PP set_VBD out_RP to_TO determine_VB whether_IN CD55_NP and/or_CC CD46_NP could_MD serve_VB as_IN cellular_JJ receptors_NNS for_IN human_JJ adenoviruses_NNS ._SENT Cells_NNS ,_, viruses_NNS ,_, antibodies_NNS ,_, and_CC recombinant_JJ fiber_NN knobs_NNS ._SENT (_( i_NP )_) Cells_NP ._SENT |_SYM Human_NP respiratory_JJ epithelial_JJ A549_NP cells_NNS were_VBD grown_VBN in_IN Dulbecco_NP modified_JJ Eagle_NP medium_NN (_( DMEM_NP ;_: Sigma_NP Chemical_NP Co._NP ,_, St._NP Louis_NP ,_, Mo._NP )_) ,_, containing_VBG 10_CD %_NN fetal_JJ calf_NN serum_NN (_( FCS_NN )_) ,_, HEPES_NP ,_, and_CC penicillin-streptomycin_NN (_( all_DT from_IN Sigma_NP )_) ._SENT Chinese_JJ hamster_NN ovary_NN (_( CHO_NP )_) cells_NNS ,_, including_VBG CHO_NP cells_NNS expressing_VBG human_JJ CAR_NN ,_, DAF_NP (_( CD55_NP )_) ,_, or_CC MCP_NP (_( CD46_NP )_) isoforms_VBZ BC1_NP or_CC BC2_NP have_VBP been_VBN described_VBN elsewhere_RB ._SENT (_( ii_NP )_) Viruses_NP ._SENT |_SYM Ad5_NP (_( strain_NN Ad75_NP )_) ,_, Ad7_JJ (_( Gomen_NP )_) ,_, Ad11_NP (_( Slobitski_NP )_) ,_, and_CC Ad37_JJ (_( 1477_CD )_) virions_NNS were_VBD propagated_VBN in_IN A549_NP cells_NNS with_IN or_CC without_IN isotope_NN labeling_VBG and_CC were_VBD purified_VBN as_IN described_VBN elsewhere_RB ._SENT The_DT specific_JJ activities_NNS for_IN each_DT serotype_NN were_VBD 1.5_CD x_SYM 10-5_CD cpm/particle_NN (_( Ad5_NP )_) ,_, 1.4_CD x_SYM 10-5_CD (_( Ad7_JJ )_) ,_, 8.1_CD x_SYM 10-6_CD (_( Ad11_NP )_) ,_, and_CC 9.4_CD x_NN 10-5_CD (_( Ad37_JJ )_) ._SENT The_DT correct_JJ identity_NN of_IN each_DT virus_NN strain_NN was_VBD confirmed_VBN by_IN restriction_NN enzyme_NN digestion_NN of_IN purified_VBN virus_NN genomes_NNS (_( data_NNS not_RB shown_VBN )_) ._SENT (_( iii_NP )_) Antibodies_NNS ._SENT |_SYM Mouse_NP monoclonal_NN antibodies_NNS (_( clones_NNS GB24_NP and_CC TRA-2-10_NP )_) and_CC rabbit_VB polyclonal_JJ antibodies_NNS to_TO human_JJ CD46_NP have_VBP been_VBN described_VBN elsewhere_RB ._SENT Mouse_NN monoclonal_NN antibodies_NNS (_( clone_NN E4.3_NN )_) against_IN human_JJ CD46_NP were_VBD purchased_VBN from_IN Ancell_NP ,_, Bayport_NP ,_, Minn._NP Monoclonal_NP anti-CD55_NP (_( IF7_JJ )_) and_CC anti-CAR_NN (_( RmcB_NP )_) antibodies_NNS were_VBD kindly_RB provided_VBN by_IN J._NP M._NP Bergelson_NP ,_, Children_NP 's_POS Hospital_NP of_IN Philadelphia_NP ,_, Philadelphia_NP ,_, Pa._NP Rabbit_NP polyclonal_JJ anti-Ad5_NN ,_, anti-Ad7_JJ ,_, anti-Ad11_JJ ,_, and_CC anti-Ad37_JJ antisera_NN were_VBD prepared_VBN as_IN described_VBN elsewhere_RB ._SENT (_( iv_NP )_) Recombinant_NP fiber_NN knobs_NNS ._SENT |_SYM DNA_NN isolations_NNS and_CC manipulations_NNS were_VBD performed_VBN by_IN standard_JJ techniques_NNS ._SENT DNA_NP fragments_VBZ encoding_VBG the_DT fiber_NN knob_NN of_IN Ad11p_NP (_( fk11p_NN )_) were_VBD amplified_VBN by_IN PCR_NP with_IN the_DT following_VBG primers_NNS ,_, preserving_VBG the_DT last_JJ shaft_NN motif_NN and_CC the_DT trimerization_NN signal_NN ,_, as_RB described_VBD earlier_RBR :_: fk11p_NN forward_RB (_( 5'-GTA_NP CTG_NP GCC_NP ATG_NP GGA_NP CTT_NP ACA_NP TTC_NP AAT_NP TC03_NP '_'' )_) and_CC fk11p_NN reverse_NN (_( 5'-GC_NP TAC_NP GCA_NP GGA_NP TCC_NP TCA_NP GTC_NP GTC_NP TTC_NP TCT_NP GAT_NP G-3_NP '_'' )_) ._SENT The_DT PCR_NP products_NNS were_VBD cloned_VBN into_IN a_DT pET-3d_JJ expression_NN vector_NN (_( Novagen_NP ,_, Madison_NP ,_, Wis._NP )_) containing_VBG an_DT N-terminal_JJ His6_NN tag_NN motif_NN by_IN using_VBG NcoI-BamHI_NP restriction_NN sites_NNS ._SENT The_DT constructs_NNS were_VBD confirmed_VBN by_IN nucleotide_NN sequence_NN analysis_NN ._SENT Proteins_NNS were_VBD expressed_VBN in_IN E._NP coli_NNS (_( strain_NN BL21_NP )_) and_CC purified_VBN by_IN using_VBG Ni-nitrilotriacetic_JJ acid_NN (_( NTA_NP )_) agarose_NN according_VBG to_TO the_DT instructions_NNS of_IN the_DT manufacturer_NN (_( Qiagen_NP ,_, Hilden_NP ,_, Germany_NP )_) ._SENT Virion-binding_JJ assays_NNS ._SENT |_SYM Unless_IN otherwise_RB stated_VBN ,_, the_DT binding_JJ assays_NNS were_VBD performed_VBN at_IN least_JJS twice_RB with_IN duplicate_JJ samples_NNS in_IN a_DT final_JJ volume_NN of_IN 100_CD mul/sample_NN by_IN using_VBG host_NN cells_NNS harvested_VBN with_IN phosphate-buffered_JJ saline_NN (_( PBS_NP )_) containing_VBG 0.05_CD %_NN (_( wt/vol_NN )_) EDTA_NP and_CC allowed_VBN to_TO recover_VB for_IN 1_CD h_NN in_IN DMEM_NP containing_VBG 10_CD %_NN FCS_NN ,_, with_IN constant_JJ agitation_NN ._SENT 35S-labeled_JJ virions_NNS were_VBD used_VBN in_IN all_DT binding_JJ experiments_NNS ._SENT Binding_JJ assays_NNS ._SENT |_SYM A_DT total_NN of_IN 2_CD x_SYM 105_CD cells/well_NN in_IN 96-well_NN microplates_NNS were_VBD incubated_VBN with_IN 104_CD virions/cell_NNS in_IN binding_JJ buffer_NN (_( BB_NP ;_: DMEM_NP ,_, penicillin-streptomycin_NP ,_, HEPES_NP ,_, and_CC 1_CD %_NN bovine_JJ serum_NN albumin_NN )_) and_CC then_RB incubated_VBN on_IN ice_NN for_IN 1_CD h._JJ Nonbound_JJ virions_NNS were_VBD removed_VBN by_IN washing_NN ,_, and_CC the_DT cell-associated_JJ radioactivity_NN was_VBD measured_VBN by_IN using_VBG a_DT Wallac_NP 1406_CD scintillation_NN counter_NN ._SENT Inhibition_NN of_IN virion_NN binding_VBG by_IN antibodies_NNS ._SENT |_SYM A_DT total_NN of_IN 105_CD cells/well_NN in_IN 96-well_NN plates_NNS were_VBD incubated_VBN on_IN ice_NN with_IN or_CC without_IN (_( control_NN )_) 5_CD mul_NN of_IN GB24_NP (_( 2.5_CD mg/ml_NN )_) ,_, TRA-2-10_NP (_( 2.5_CD mg/ml_NN )_) ,_, IF7_JJ (_( cell_NN culture_NN supernatant_JJ )_) ,_, RmcB_NP (_( ascites_NN )_) ,_, rabbit_NN anti-CD46_NN serum_NN ,_, or_CC serum_NN from_IN two_CD different_JJ nonimmunized_JJ rabbits_NNS ._SENT After_IN a_DT further_JJR 30_CD min_NN ,_, 5_CD x_SYM 103_CD virions/cell_NNS were_VBD added_VBN ,_, and_CC incubation_NN was_VBD continued_VBN on_IN ice_NN ._SENT The_DT cells_NNS were_VBD then_RB washed_VBN ,_, and_CC the_DT cell-associated_JJ radioactivity_NN was_VBD measured_VBN as_IN described_VBN above_IN ._SENT Effect_NN of_IN divalent_JJ cations_NNS on_IN virion_NN binding_NN ._SENT |_SYM A_DT total_NN of_IN 2_CD x_SYM 105_CD nonrecovered_JJ CHO_NP or_CC CHO-BC1_NP cells/well_NP in_IN 96-well_NP plates_NNS were_VBD incubated_VBN first_RB with_IN 5_CD mul_NN of_IN rabbit_NN anti-CD46_NN serum_NN on_IN ice_NN for_IN 1_CD h_NN in_IN Tris-buffered_JJ saline_NN with_IN or_CC without_IN 5_CD mM_NP CaCl2_NP ,_, MnCl2_NP ,_, or_CC MgCl2_NP and_CC then_RB incubated_VBN with_IN 104_CD virions/cell_NNS in_IN the_DT same_JJ buffer_NN ._SENT Two_CD hours_NNS later_RBR ,_, the_DT cells_NNS were_VBD washed_VBN with_IN incubation_NN medium_NN ,_, and_CC the_DT cell-associated_JJ radioactivity_NN was_VBD measured_VBN as_IN described_VBN above_IN ._SENT Effect_NN of_IN prior_JJ trypsination_NN of_IN the_DT cell_NN surface_NN on_IN virion_NN binding_NN ._SENT |_SYM Adherent_NP CHO-BC1_NP cells_NNS in_IN 75-cm2_JJ culture_NN bottles_NNS were_VBD harvested_VBN on_IN ice_NN with_IN PBS-EDTA_NP or_CC with_IN 200_CD mug_NN of_IN trypsin_NN (_( Invitrogen_NP ,_, Paisley_NP ,_, United_NP Kingdom)/ml_NP ._SENT Cells_NNS harvested_VBN with_IN PBS-EDTA_NP were_VBD recovered_VBN as_IN described_VBN above_IN ._SENT One_CD hour_NN later_RBR ,_, Pefabloc_NP C_NP (_( a_DT serine_NN protease_NN inhibitor_NN ;_: Roche_NP ,_, Basel_NP ,_, Switerland_NP )_) was_VBD added_VBN to_TO a_DT final_JJ concentration_NN of_IN 2_CD mM_NNS ,_, and_CC 10_CD ml_NN of_IN DMEM_NP containing_VBG 5_CD %_NN FCS_NN was_VBD added_VBN to_TO the_DT trypsinized_JJ cells_NNS ._SENT The_DT cells_NNS were_VBD then_RB washed_VBN ,_, and_CC 105_CD cells/well_NN in_IN 96-well_NN plates_NNS were_VBD incubated_VBN on_IN ice_NN in_IN BB_NP containing_VBG 3.6_CD x_SYM 104_CD Ad7_JJ or_CC Ad11_JJ virions/cell_NNS ._SENT Inhibition_NN of_IN virion_NN binding_VBG by_IN soluble_JJ fiber_NN knobs_NNS ._SENT |_SYM A_DT total_NN of_IN 5_CD x_SYM 104_CD cells/well_NN in_IN 96-well_NN plates_NNS were_VBD incubated_VBN on_IN ice_NN in_IN BB_NP (_( volume_NN 50_CD mul_NN )_) with_IN or_CC without_IN 0.5_CD mug_NN of_IN recombinant_JJ ,_, soluble_JJ fiber_NN knobs_NNS of_IN Ad11_NP ,_, Ad7_JJ ,_, or_CC Ad5_NP ._SENT One_CD hour_NN later_RBR ,_, 5_CD x_SYM 104_CD Ad11_JJ virions/cell_NNS were_VBD added_VBN ,_, and_CC the_DT mixtures_NNS were_VBD incubated_VBN for_IN 1_CD h._JJ Nonbound_JJ virions_NNS were_VBD removed_VBN by_IN washing_NN ,_, and_CC the_DT cell-associated_JJ radioactivity_NN was_VBD measured_VBN as_IN described_VBN above_IN ._SENT Flow_NN cytometry_NN ._SENT |_SYM Expression_NN levels_NNS of_IN CD46_NP on_IN A549_NP ,_, CHO_NP ,_, CHO-BC1_NP and_CC CHO-BC2_NP cells_NNS were_VBD investigated_VBN by_IN using_VBG mouse_NN monoclonal_NN (_( E4.3_NP )_) anti-human_NP CD46_NP antibodies_NNS (_( 1_CD mg/ml_NN )_) diluted_VBN 1:200_CD in_IN PBS_NP supplemented_VBD with_IN 10_CD %_NN FCS_NN and_CC 0.01_CD %_NN NaN3_NP (_( staining_VBG buffer_NN )_) ._SENT A_DT total_NN of_IN 105_CD cells_NNS were_VBD incubated_VBN with_IN the_DT diluted_JJ primary_JJ antibody_NN in_IN a_DT volume_NN of_IN 100_CD mul_NN for_IN 45_CD min_NN on_IN ice_NN and_CC thereafter_RB washed_VBN once_RB in_IN 200_CD mul_NN of_IN staining_VBG buffer_NN ._SENT For_IN detection_NN ,_, fluorescein_NN isothiocyanate-conjugated_JJ rabbit_NN anti-mouse_NP Fab_NP fragments_NNS were_VBD used_VBN (_( Dako_NP ,_, Glostrup_NP ,_, Denmark_NP )_) that_WDT were_VBD diluted_VBN 1:20_CD in_IN staining_VBG buffer_NN ._SENT After_IN incubation_NN for_IN 45_CD min_NN on_IN ice_NN ,_, the_DT cells_NNS were_VBD washed_VBN as_IN described_VBN above_IN and_CC analyzed_VBD in_IN a_DT FACScan_NP (_( Becton_NP Dickinson_NP )_) flow_NN cytometer_NN ._SENT The_DT data_NNS were_VBD analyzed_VBN by_IN using_VBG CellQuest_NP software_NN (_( Becton_NP Dickinson_NP )_) ._SENT Fluorescent_JJ focus_NN assay_NN ._SENT |_SYM A_DT total_NN of_IN 1.5_CD x_SYM 105_CD adherent_JJ cells/well_NN in_IN 24-well_JJ plates_NNS were_VBD incubated_VBN with_IN 90,000_CD virus_NN particles/cell_NN on_IN ice_NN to_TO synchronize_VB infection_NN ._SENT One_CD hour_NN later_RBR ,_, nonbound_JJ virions_NNS were_VBD removed_VBN by_IN washing_NN ._SENT In_IN some_DT cases_NNS ,_, 18_CD mul_NN of_IN rabbit_NN anti-CD46_NN serum_NN or_CC serum_NN from_IN nonimmunized_JJ rabbits_NNS was_VBD incubated_VBN with_IN the_DT cells_NNS on_IN ice_NN in_IN a_DT final_JJ volume_NN of_IN 300_CD mul_NN before_IN virions_NNS were_VBD added_VBN ._SENT After_IN incubation_NN for_IN 44_CD h_NN at_IN 37C_NP ,_, the_DT cells_NNS were_VBD fixed_VBN in_IN methanol_NN and_CC stained_VBN with_IN polyclonal_JJ rabbit_NN serum_NN raised_VBN against_IN Ad11_JJ virions_NNS ,_, followed_VBN by_IN fluorescein_NN isothiocyanate-conjugated_JJ swine_NN anti-rabbit_NN immunoglobulin_NN G_NN antibodies_NNS (_( Dako_NP )_) ._SENT Infected_JJ cells_NNS were_VBD then_RB identified_VBN in_IN a_DT fluorescence_NN microscope_NN (_( x100_JJ magnification_NN ;_: Xiovert_NP 25_CD ;_: Carl_NP Zeiss_NP ,_, Jena_NP ,_, Germany_NP )_) as_RB described_VBD previously_RB ._SENT Expression_NN of_IN human_JJ CD46_NP on_IN CHO_NP cells_NNS enhances_VBZ binding_VBG of_IN Ad7_JJ and_CC Ad11_JJ virions_NNS ._SENT |_SYM In_IN a_DT first_JJ experiment_NN ,_, we_PP investigated_VBD the_DT ability_NN of_IN several_JJ 35S-labeled_JJ adenovirus_NN serotypes_NNS to_TO bind_VB to_TO CHO_NP cells_NNS transfected_VBN with_IN cDNAs_NNS encoding_VBG human_JJ CAR_NN ,_, DAF_NP ,_, or_CC two_CD isoforms_NNS of_IN CD46_NP designated_VBN BC1_NP and_CC BC2_NP ._SENT As_IN expected_VBN ,_, Ad5_NP virions_NNS attached_VBN to_TO CHO-CAR_NN cells_NNS 20_CD times_NNS more_RBR efficiently_RB than_IN to_TO the_DT other_JJ transfectants_NNS ._SENT Ad37_JJ virions_NNS attached_VBN to_TO all_DT transfectants_NNS with_IN similar_JJ efficiency_NN ,_, which_WDT is_VBZ in_IN agreement_NN with_IN the_DT apparent_JJ ability_NN of_IN this_DT virus_NN to_TO use_VB sialic_JJ acid_NN as_IN a_DT cellular_JJ receptor_NN ._SENT Ad7_JJ virions_NNS attached_VBN to_TO CHO-BC1_NP cells_NNS three_CD to_TO four_CD times_NNS more_RBR efficiently_RB than_IN to_TO the_DT other_JJ cells_NNS ,_, including_VBG the_DT CHO-BC2_JJ cells_NNS ._SENT Ad11_JJ virions_NNS attached_VBN at_IN least_JJS 10_CD times_NNS more_RBR efficiently_RB to_TO CHO-BC1_JJ cells_NNS and_CC 4_CD times_NNS more_RBR efficiently_RB to_TO CHO-BC2_JJ cells_NNS than_IN to_TO CHO-CAR_NN cells_NNS and_CC CHO-DAF_NN cells_NNS ._SENT The_DT only_JJ differences_NNS between_IN the_DT BC1_NP and_CC BC2_NP isoforms_NNS reside_VBP in_IN their_PP$ cytoplasmic_JJ domains_NNS ._SENT Thus_RB ,_, the_DT extracellular_JJ domains_NNS are_VBP identical_JJ and_CC could_MD not_RB account_VB for_IN differences_NNS in_IN virus_NN binding_NN ._SENT Instead_RB ,_, the_DT differences_NNS in_IN the_DT binding_NN of_IN Ad7_JJ or_CC Ad11_JJ virions_NNS to_TO CHO-BC1_NP and_CC CHO-BC2_NP cells_NNS is_VBZ in_IN line_NN with_IN the_DT higher_JJR expression_NN of_IN the_DT BC1_JJ isoform_NN on_IN CHO_NP cells_NNS compared_VBN to_TO the_DT expression_NN of_IN the_DT BC2_NP isoform_NN ._SENT These_DT experiments_NNS indicated_VBD that_IN Ad11_NP and_CC ,_, to_TO some_DT extent_NN ,_, Ad7_JJ interact_VBP with_IN cell_NN surface_NN CD46_NP proteins_VBZ ._SENT Anti-CD46_JJ antibodies_NNS inhibit_VBP binding_VBG of_IN Ad7_JJ and_CC Ad11_JJ virions_NNS to_TO CHO-BC1_JJ cells_NNS ._SENT |_SYM In_IN a_DT second_JJ experiment_NN ,_, we_PP preincubated_VBD A549_NP cells_NNS or_CC CHO-BC1_JJ cells_NNS with_IN antibodies_NNS to_TO CD46_NP ,_, CAR_NP ,_, or_CC CD55_NP and_CC investigated_VBD the_DT effect_NN on_IN virus_NN binding_NN ._SENT Monoclonal_NN antibodies_NNS to_TO CAR_NP (_( RmcB_NP )_) or_CC CD55_NP (_( IF7_NP )_) had_VBD no_DT effect_NN on_IN the_DT binding_NN of_IN Ad7_JJ and_CC Ad11_JJ ._SENT Serum_NN from_IN nonimmunized_JJ rabbits_NNS was_VBD also_RB ineffective_JJ ._SENT However_RB ,_, rabbit_NN anti-CD46_NN serum_NN efficiently_RB inhibited_VBD the_DT binding_NN of_IN both_DT Ad7_JJ and_CC Ad11_JJ to_TO CHO-BC1_JJ cells_NNS to_TO background_NN levels_NNS ,_, indicating_VBG that_IN these_DT antibodies_NNS blocked_VBD all_DT specific_JJ binding_JJ sites_NNS ._SENT Moreover_RB ,_, the_DT anti-CD46_JJ monoclonal_NN antibody_NN GB24_NP also_RB inhibited_VBD binding_VBG of_IN Ad7_JJ and_CC Ad11_JJ to_TO CHO-BC1_JJ cells_NNS to_TO background_NN levels_NNS (_( Ad7_JJ )_) or_CC close_VB to_TO background_NN levels_NNS (_( Ad11_NP )_) ,_, whereas_IN the_DT ability_NN of_IN anti-CD46_JJ monoclonal_NN antibody_NN TRA-2-10_NP to_TO inhibit_VB binding_JJ was_VBD considerably_RB less_JJR ._SENT GB24_NP recognizes_VBZ an_DT epitope_NN located_VBN in_IN the_DT SCR3/4_NP region_NN ,_, and_CC TRA-2-10_NP recognizes_VBZ an_DT epitope_NN in_IN the_DT SCR1_NP region_NN ,_, which_WDT suggests_VBZ that_IN the_DT virus-binding_JJ site_NN is_VBZ located_VBN near_IN the_DT cell_NN membrane_NN rather_RB than_IN being_VBG in_IN the_DT membrane-distal_JJ domain_NN of_IN CD46_NP ._SENT Both_DT GB24_NP and_CC rabbit_VB polyclonal_JJ anti-CD46_NN inhibited_VBD the_DT binding_NN of_IN Ad11_NP to_TO A549_NP cells_NNS but_CC did_VBD not_RB completely_RB block_VB binding_JJ ._SENT Also_RB ,_, none_NN of_IN the_DT anti-CD46_JJ antibodies_NNS inhibited_VBD the_DT binding_NN of_IN Ad7_JJ to_TO A549_NP cells_NNS ,_, indicating_VBG that_IN A549_NP cells_NNS exhibit_VBP additional_JJ receptor_NN sites_NNS for_IN both_DT Ad7_JJ and_CC Ad11_JJ ._SENT Thus_RB ,_, these_DT results_NNS indicated_VBD that_IN our_PP$ previous_JJ hypothesis_NN about_IN two_CD different_JJ cellular_JJ receptors_NNS for_IN species_NN B_NN adenoviruses_NNS is_VBZ correct_JJ and_CC that_IN CD46_NP may_MD be_VB equivalent_JJ to_TO the_DT previously_RB suggested_VBN species_NNS B:2_JJ adenovirus_NN receptor_NN (_( sB2AR_NN )_) ._SENT Expression_NN of_IN CD46_NP is_VBZ required_VBN for_IN efficient_JJ infection_NN of_IN CHO_NP cells_NNS by_IN Ad11_JJ virions_NNS ._SENT |_SYM To_TO investigate_VB whether_IN CD46_NP was_VBD involved_VBN in_IN infection_NN ,_, and_CC not_RB only_JJ attachment_NN ,_, we_PP allowed_VBD virions_NNS to_TO attach_VB and_CC infect_VB CHO_NP ,_, CHO-BC1_NP ,_, and_CC CHO-BC2_NP cells_NNS ._SENT Ad11-infected_NP CHO-BC1_NP and_CC CHO-BC2_NP cells_NNS more_RBR efficiently_RB than_IN it_PP infected_VBD CHO_NP cells_NNS ,_, indicating_VBG that_IN the_DT presence_NN of_IN CD46_NP facilitates_VBZ both_DT attachment_NN and_CC subsequent_JJ infection_NN by_IN Ad11_NP ._SENT On_IN the_DT other_JJ hand_NN ,_, Ad7_JJ did_VBD not_RB infect_VB any_DT of_IN the_DT transfectants_NNS ,_, including_VBG the_DT CHO-BC1_JJ cells_NNS ,_, suggesting_VBG that_IN even_RB if_IN the_DT presence_NN of_IN CD46_NP facilitates_VBZ attachment_NN of_IN Ad7_JJ ,_, it_PP is_VBZ not_RB sufficient_JJ to_TO support_VB infection_NN ._SENT The_DT inhibitory_JJ effect_NN of_IN the_DT rabbit_NN anti-CD46_NN serum_NN was_VBD also_RB confirmed_VBN in_IN an_DT infectivity_NN assay_NN ._SENT Anti-CD46_JJ serum_NN efficiently_RB inhibited_VBD Ad11_JJ infection_NN of_IN BC1_JJ cells_NNS ,_, whereas_IN sera_NN from_IN two_CD nonimmunized_JJ rabbits_NNS did_VBD not_RB affect_VB infection_NN ._SENT However_RB ,_, rabbit_NN anti-CD46_NN serum_NN did_VBD not_RB inhibit_VB Ad11_JJ infection_NN of_IN A549_NP cells_NNS ,_, indicating_VBG that_IN these_DT cells_NNS express_VBP additional_JJ receptors_NNS beside_IN CD46_NP ,_, which_WDT are_VBP able_JJ to_TO support_VB infection_NN of_IN Ad11_JJ (_( data_NNS not_RB shown_VBN )_) ._SENT Ca2+_NP and_CC Mn2+_NP ions_NNS are_VBP required_VBN for_IN the_DT efficient_JJ binding_NN of_IN Ad7_JJ to_TO CHO-BC1_JJ cells_NNS ._SENT |_SYM In_IN an_DT earlier_JJR publication_NN ,_, we_PP demonstrated_VBD that_IN species_NN B:1_NP viruses_NNS Ad3_NP and_CC Ad7_NP require_VBP Ca2+_NP ions_NNS for_IN binding_VBG to_TO host_NN cells_NNS ,_, whereas_IN species_NNS B:2_NP viruses_NNS attach_VBP to_TO host_VB cells_NNS almost_RB independently_RB of_IN Ca2+_NP and_CC Mg2+_NP ions_NNS ._SENT To_TO test_VB whether_IN divalent_JJ cations_NNS are_VBP involved_VBN in_IN the_DT binding_NN of_IN species_NN B_NN adenoviruses_NNS to_TO CD46-expressing_NP cells_NNS ,_, we_PP harvested_VBD CHO-BC1_NP and_CC CHO-BC2_NP cells_NNS in_IN PBS-EDTA_NP ,_, thus_RB removing_VBG all_DT divalent_JJ cations_NNS ,_, and_CC then_RB incubated_VBD the_DT cells_NNS with_IN 35S-labeled_JJ Ad7_JJ or_CC Ad11_JJ virions_NNS in_IN the_DT presence_NN of_IN Ca2+_NP ,_, Mn2+_NP ,_, or_CC Mg2+_NP ions_NNS ._SENT The_DT binding_NN of_IN Ad7_JJ virions_NNS to_TO CHO-BC1_JJ cells_NNS was_VBD strongly_RB enhanced_VBN in_IN the_DT presence_NN of_IN Mn2+_NP ions_NNS and_CC moderately_RB enhanced_VBN in_IN the_DT presence_NN of_IN Ca2+_NP and_CC Mg2+_NP ions_NNS ,_, whereas_IN the_DT binding_NN of_IN Ad11_JJ virions_NNS to_TO CHO-BC1_JJ cells_NNS was_VBD doubled_VBN in_IN the_DT presence_NN of_IN Mn2+_NP and_CC unchanged_JJ in_IN the_DT presence_NN of_IN Ca2+_NP or_CC Mg2+_NP ions_NNS ._SENT Rabbit_NN anti-CD46_NN serum_NN efficiently_RB inhibited_VBD the_DT binding_NN of_IN both_DT Ad7_JJ and_CC Ad11_JJ to_TO CHO-BC1_JJ cells_NNS in_IN the_DT presence_NN of_IN divalent_JJ ions_NNS ._SENT Thus_RB ,_, binding_VBG of_IN Ad7_JJ to_TO CD46-expressing_NP CHO_NP cells_NNS requires_VBZ Ca2+_NP or_CC Mn2+_NP ions_NNS ,_, whereas_IN Ad11_JJ virions_NNS are_VBP able_JJ to_TO interact_VB with_IN CD46-expressing_NP cells_NNS in_IN the_DT absence_NN of_IN divalent_JJ cations_NNS ._SENT Furthermore_RB ,_, divalent_JJ ions_NNS enhanced_VBD the_DT binding_NN of_IN Ad7_JJ to_TO CD46-negative_NP CHO_NP cells_NNS with_IN the_DT same_JJ efficiency_NN as_RB to_TO CD46-positive_JJ cells_NNS ,_, indicating_VBG that_IN the_DT divalent-ion_NN dependent_JJ binding_NN of_IN Ad7_JJ was_VBD independent_JJ of_IN the_DT presence_NN of_IN CD46_NP ._SENT Prior_JJ trypsination_NN of_IN CHO-BC1_JJ cells_NNS inhibits_VBZ the_DT binding_NN of_IN Ad7_JJ virions_NNS but_CC enhances_VBZ the_DT binding_NN of_IN Ad11_JJ virions_NNS ._SENT |_SYM It_PP has_VBZ been_VBN shown_VBN previously_RB that_IN prior_JJ trypsination_NN of_IN A549_NP cells_NNS inhibits_VBZ the_DT binding_NN of_IN Ad3_NP and_CC Ad7_JJ virions_NNS and_CC enhances_VBZ the_DT binding_NN of_IN Ad11_NP and_CC Ad35_NP virions_NNS ._SENT To_TO investigate_VB whether_IN adenovirus_NN binding_VBG to_TO CD46_NP is_VBZ affected_VBN by_IN cellular_JJ trypsination_NN ,_, we_PP pretreated_VBD CHO-BC1_JJ cells_NNS with_IN trypsin_NN and_CC investigated_VBD the_DT binding_NN of_IN Ad7_JJ and_CC Ad11_JJ virions_NNS to_TO these_DT cells_NNS ._SENT In_IN agreement_NN with_IN previous_JJ results_NNS (_( using_VBG A549_NP cells_NNS )_) ,_, we_PP found_VBD that_IN the_DT binding_NN of_IN Ad11_NP to_TO CHO-BC1_NP cells_NNS was_VBD increased_VBN by_IN 41_CD %_NN ,_, which_WDT supports_VBZ our_PP$ hypothesis_NN that_IN CD46_NP is_VBZ sB2AR_JJ ._SENT In_IN the_DT case_NN of_IN Ad7_JJ ,_, the_DT binding_NN to_TO CHO-BC1_JJ cells_NNS was_VBD reduced_VBN to_TO background_NN levels_NNS ,_, indicating_VBG that_IN all_DT specific_JJ binding_JJ sites_NNS were_VBD abolished_VBN ._SENT Soluble_JJ fiber_NN knobs_NNS inhibit_VBP the_DT binding_NN of_IN Ad11_JJ virions_NNS to_TO CHO-BC1_JJ cells_NNS ._SENT |_SYM Most_JJS adenoviruses_NNS ,_, including_VBG species_NN B_NN adenoviruses_NNS ,_, attach_VBP to_TO host_VB cells_NNS mainly_RB through_IN an_DT interaction_NN mediated_VBN by_IN the_DT knob_NN domain_NN of_IN the_DT viral_JJ fiber_NN protein_NN ._SENT To_TO investigate_VB whether_IN species_NN B_NN adenoviruses_NNS use_VBP the_DT fiber_NN knob_NN for_IN attachment_NN to_TO A549_NP and_CC CHO-BC1_NP cells_NNS ,_, we_PP preincubated_VBD these_DT cells_NNS with_IN soluble_JJ recombinant_JJ Ad11_JJ fiber_NN knobs_NNS and_CC then_RB added_VBD homologous_JJ 35S-labeled_JJ virions_NNS ._SENT As_IN expected_VBN ,_, soluble_JJ knobs_NNS inhibited_VBD the_DT binding_NN of_IN homologous_JJ virions_NNS to_TO A549_NP and_CC CHO-BC1_NP cells_NNS by_IN 82_CD and_CC 93_CD %_NN ,_, respectively_RB ._SENT Thus_RB ,_, soluble_JJ Ad11_JJ knobs_NNS efficiently_RB inhibited_VBD the_DT binding_NN of_IN homologous_JJ virions_NNS to_TO both_DT A549_NP and_CC CHO-BC1_NP cells_NNS ,_, indicating_VBG that_IN the_DT knob_NN domain_NN of_IN the_DT viral_JJ fiber_NN protein_NN mediates_VBZ Ad11_JJ interactions_NNS with_IN CD46_NP ._SENT Fiber_NN knobs_NNS from_IN Ad7_NP or_CC Ad5_NP did_VBD not_RB compete_VB with_IN Ad11_JJ virions_NNS for_IN binding_VBG to_TO CHO-BC1_JJ cells_NNS ,_, which_WDT is_VBZ in_IN agreement_NN with_IN our_PP$ conclusion_NN that_IN CD46_NP is_VBZ utilized_VBN as_IN a_DT cellular_JJ receptor_NN by_IN Ad11_NP but_CC not_RB by_IN Ad7_JJ or_CC other_JJ serotypes_NNS ._SENT In_IN humans_NNS ,_, a_DT cluster_NN of_IN genes_NNS designated_VBN the_DT RCA_NP (_( for_IN regulator_NN of_IN complement_NN activation_NN )_) gene_NN cluster_NN is_VBZ located_VBN on_IN the_DT long_JJ arm_NN of_IN chromosome_NN 1_CD (_( 1q32_JJ )_) ._SENT Although_IN the_DT proteins_NNS within_IN the_DT RCA_NP family_NN vary_VBP in_IN size_NN ,_, they_PP have_VBP significant_JJ similarities_NNS in_IN primary_JJ structure_NN ._SENT Some_DT of_IN the_DT primary_JJ sequence_NN is_VBZ organized_VBN in_IN tandem_JJ structural_JJ units_NNS termed_VBD short_JJ consensus_NN repeats_NNS (_( SCRs_NP )_) ,_, which_WDT are_VBP present_JJ in_IN multiple_JJ copies_NNS in_IN the_DT protein_NN ._SENT Thirteen_CD different_JJ SCR-containing_NP proteins_NNS in_IN the_DT complement_NN system_NN have_VBP been_VBN identified_VBN ._SENT At_IN least_JJS three_CD of_IN these13_NN (_( CD55_NP ,_, CD46_NP ,_, and_CC complement_VB receptor_NN 1_CD [_SYM CR1_NP ]_SYM )_) are_VBP associated_VBN with_IN host_NN cell_NN membranes_NNS ._SENT Both_DT CD55_NP and_CC CD46_NP contain_VBP 4_CD SCRs_NN ,_, whereas_IN CR1_NP contains_VBZ between_IN 23_CD and_CC 44_CD SCRs_NNS ,_, depending_VBG on_IN the_DT isoform_NN ._SENT CD55_NP is_VBZ linked_VBN to_TO the_DT cell_NN membrane_NN via_IN a_DT glycosyl_NN phosphatidylinositol_NN anchor_NN ,_, whereas_IN CD46_NP and_CC CR1_NP contain_VBP a_DT transmembrane_NN domain_NN ._SENT Despite_IN the_DT different_JJ forms_NNS of_IN membrane_NN linkage_NN in_IN CD46_NP and_CC CD55_NP ,_, the_DT overall_JJ amino_NN acid_NN identity_NN is_VBZ 45_CD %_NN ._SENT In_IN terms_NNS of_IN receptor_NN usage_NN ,_, adenoviruses_NNS share_VBP many_JJ features_NNS with_IN picornaviruses_NNS ._SENT Since_IN many_JJ picornaviruses_NNS use_VBP CD55_NP as_IN a_DT cellular_JJ receptor_NN ,_, we_PP hypothesized_VBD that_IN members_NNS of_IN the_DT adenovirus_NN family_NN may_MD use_VB CD55_NP or_CC its_PP$ close_JJ relative_JJ CD46_NN as_IN a_DT cellular_JJ receptor_NN ._SENT CD55_NP is_VBZ expressed_VBN widely_RB throughout_IN the_DT body_NN but_CC in_IN relatively_RB low_JJ quantity_NN on_IN natural_JJ killer_NN cells_NNS ._SENT CD46_NP serves_VBZ as_IN a_DT cellular_JJ receptor_NN for_IN certain_JJ strains_NNS of_IN measles_NN virus_NN and_CC human_JJ herpesvirus_NN 6_CD and_CC is_VBZ expressed_VBN in_IN many_JJ different_JJ tissues_NNS ,_, but_CC the_DT expression_NN appears_VBZ to_TO be_VB higher_JJR in_IN the_DT kidney_NN and_CC in_IN the_DT airway_NN and_CC conjunctival_JJ epithelium_NN ._SENT Thus_RB ,_, the_DT expression_NN of_IN CD46_NP correlates_VBZ well_RB with_IN the_DT tropism_NN of_IN most_JJS species_NNS B:2_JJ adenoviruses_NNS (_( i.e._FW ,_, Ad11_NP ,_, Ad34_NP ,_, and_CC Ad35_NP )_) ._SENT Here_RB we_PP have_VBP demonstrated_VBN that_IN Ad11_NP interacts_VBZ with_IN human_JJ CD46-expressing_NP CHO_NP cells_NNS but_CC not_RB with_IN equivalent_JJ cells_NNS expressing_VBG CD55_NP or_CC CAR_NP instead_RB and_CC that_IN anti-CD46_JJ antibodies_NNS efficiently_RB inhibit_VBP the_DT binding_NN of_IN Ad11_NP to_TO CD46-expressing_NP CHO_NP cells_NNS ,_, indicating_VBG that_IN the_DT presence_NN of_IN CD46_NP on_IN the_DT surface_NN of_IN host_NN cells_NNS provides_VBZ Ad11_JJ with_IN novel_JJ virus-binding_NN sites_NNS ._SENT Also_RB ,_, the_DT presence_NN of_IN CD46_NP converted_VBD nonpermissive_JJ CHO_NP cells_NNS to_TO be_VB permissive_JJ for_IN Ad11_JJ infection_NN ,_, and_CC this_DT infection_NN could_MD be_VB blocked_VBN with_IN anti-CD46_JJ antibodies_NNS ._SENT Furthermore_RB ,_, soluble_JJ Ad11_JJ fiber_NN knobs_NNS efficiently_RB inhibited_VBD the_DT binding_NN of_IN Ad11_NP to_TO CD46-positive_JJ cells_NNS ,_, indicating_VBG that_IN Ad11_NP ,_, like_IN most_RBS other_JJ adenoviruses_NNS ,_, uses_VBZ the_DT knob_NN domain_NN of_IN the_DT viral_JJ fiber_NN protein_NN for_IN interactions_NNS with_IN host_NN cell_NN receptors_NNS ._SENT Taken_VBN together_RB ,_, these_DT results_NNS demonstrate_VBP that_IN CD46_NP may_MD serve_VB as_IN a_DT cellular_JJ receptor_NN for_IN Ad11_NP ._SENT We_PP have_VBP previously_RB suggested_VBN that_IN all_DT species_NN B_NN adenoviruses_NNS (_( including_VBG Ad7_JJ and_CC Ad11_JJ )_) use_VBP the_DT cellular_JJ receptor_NN designated_VBN sBAR_NN and_CC that_DT species_NNS B:2_NP adenoviruses_NNS may_MD use_VB an_DT additional_JJ receptor_NN designated_VBN sB2AR_NN ._SENT Here_RB we_PP found_VBD a_DT clear_JJ difference_NN in_IN the_DT interactions_NNS of_IN Ad7_JJ (_( species_NN B:1_NP )_) and_CC Ad11_NP (_( species_NN B:2_NP )_) with_IN CD46_NP ._SENT Ad7_JJ bound_NN to_TO CD46-expressing_NP cells_NNS less_RBR efficiently_RB than_IN Ad11_NP and_CC was_VBD also_RB unable_JJ to_TO infect_VB CD46-expressing_NP CHO_NP cells_NNS ._SENT Also_RB ,_, anti-CD46_JJ antibodies_NNS inhibited_VBD the_DT binding_NN of_IN Ad11_NP to_TO A549_NP cells_NNS but_CC not_RB the_DT binding_NN of_IN Ad7_JJ to_TO the_DT same_JJ cells_NNS ._SENT Moreover_RB ,_, the_DT binding_NN of_IN Ad11_JJ virions_NNS to_TO CD46-expressing_NP cells_NNS was_VBD not_RB dependent_JJ on_IN divalent_JJ cations_NNS and_CC was_VBD elevated_VBN upon_IN pretreatment_NN of_IN the_DT cells_NNS with_IN trypsin_NN ,_, whereas_IN the_DT binding_NN of_IN Ad7_JJ was_VBD almost_RB entirely_RB dependent_JJ on_IN divalent_JJ cations_NNS ,_, and_CC the_DT binding_NN was_VBD reduced_VBN after_IN trypsination_NN ._SENT Finally_RB ,_, Ad7_JJ knobs_NNS did_VBD not_RB compete_VB with_IN Ad11_JJ virions_NNS for_IN binding_VBG to_TO CD46-expressing_NP CHO_NP cells_NNS ._SENT Thus_RB ,_, these_DT experiments_NNS confirm_VBP our_PP$ previous_JJ suggestion_NN about_IN two_CD cellular_JJ receptors_NNS for_IN species_NN B_NN adenoviruses_NNS ._SENT The_DT finding_NN that_IN rabbit_NN anti-CD46_NN serum_NN inhibits_VBZ the_DT binding_NN of_IN Ad7_JJ to_TO CHO-BC1_JJ cells_NNS stimulated_VBN with_IN divalent_JJ ions_NNS suggests_VBZ that_IN the_DT cellular_JJ receptor_NN for_IN Ad7_JJ is_VBZ in_IN close_JJ proximity_NN to_TO CD46_NP rather_RB than_IN being_VBG CD46_JJ itself_PP ._SENT The_DT finding_NN that_IN Ad7_JJ binds_NNS to_TO CD46-negative_NP CHO_NP cells_NNS with_IN the_DT same_JJ efficiency_NN as_RB to_TO CD46-positive_JJ cells_NNS supports_VBZ this_DT suggestion_NN ._SENT Since_IN Ad11_NP and_CC Ad35_NP (_( also_RB species_NN B:2_NN )_) compete_VBP for_IN the_DT same_JJ receptor_NN site_NN and_CC Ad34_NP (_( the_DT third_JJ of_IN four_CD species_NNS B:2_NP adenoviruses_NNS )_) exhibits_VBZ high_JJ amino_NN acid_NN homology_NN with_IN Ad11_NP in_IN the_DT fiber_NN knob_NN (_( 99.5_CD %_NN )_) ,_, we_PP propose_VBP that_IN the_DT previously_RB designated_VBN species_NNS B:2_JJ adenovirus_NN receptor_NN (_( sB2AR_NN )_) is_VBZ equivalent_JJ to_TO CD46_NP ._SENT The_DT identity_NN of_IN sBAR_NN remains_VBZ to_TO be_VB determined_VBN ,_, and_CC the_DT role_NN of_IN CD46_NP as_IN a_DT cellular_JJ receptor_NN for_IN Ad7_JJ and_CC other_JJ species_NNS B:1_JJ adenoviruses_NNS (_( i.e._FW ,_, Ad3_NP ,_, Ad16_NP ,_, Ad21_NP ,_, and_CC Ad51_NP )_) requires_VBZ further_JJR evaluation_NN ,_, but_CC our_PP$ results_NNS suggest_VBP two_CD possible_JJ mechanisms_NNS for_IN Ad7_JJ binding_NN to_TO host_NN cells_NNS ._SENT (_( i_NP )_) Ad7_NP uses_VBZ a_DT different_JJ isoform_NN of_IN CD46_NP as_IN a_DT cellular_JJ receptor_NN ,_, and_CC the_DT isoforms_NNS used_VBN in_IN the_DT present_JJ study_NN contain_VBP a_DT partial_JJ region_NN of_IN the_DT binding_JJ site_NN ,_, which_WDT is_VBZ sufficient_JJ for_IN weak_JJ binding_JJ but_CC not_RB for_IN subsequent_JJ infection_NN ._SENT (_( ii_NP )_) CD46_NP associates_NNS with_IN an_DT unknown_JJ receptor_NN in_IN the_DT cytoplasm_NN of_IN CHO_NP cells_NNS and_CC brings_VBZ this_DT receptor_NN to_TO the_DT cell_NN surface_NN ,_, where_WRB it_PP is_VBZ exposed_VBN for_IN Ad7_JJ ._SENT CD46_NP is_VBZ known_VBN to_TO associate_VB directly_RB or_CC indirectly_RB with_IN several_JJ proteins_NNS at_IN the_DT cell_NN surface_NN ,_, such_JJ as_IN the_DT alpha2beta1-_NN ,_, alpha3beta1-_NN ,_, and_CC alpha6beta1-integrins_NNS ,_, which_WDT are_VBP cell_NN surface_NN proteins_NNS that_WDT need_VBP divalent_JJ cations_NNS for_IN heterodimerization_NN and_CC interactions_NNS with_IN various_JJ ligands_NNS ._SENT Most_JJS CHO_NP cell_NN lines_NNS express_VBP few_JJ or_CC no_DT integrins_NNS on_IN the_DT cell_NN surface_NN (_( -_: )_) ._SENT beta_JJ Integrins_NP ,_, for_IN example_NN (_( including_VBG beta1_NNS [_SYM 130_CD kDa_NN ]_SYM )_) ,_, are_VBP expressed_VBN in_IN these_DT cells_NNS but_CC are_VBP usually_RB not_RB brought_VBN to_TO the_DT cell_NN surface_NN due_JJ to_TO the_DT absence_NN of_IN alpha_NN integrins_NNS ._SENT It_PP has_VBZ been_VBN shown_VBN previously_RB that_IN Ad3_NP (_( which_WDT belong_VBP to_TO the_DT same_JJ subspecies_NN as_IN Ad7_JJ )_) virions_NNS bind_NN to_TO a_DT cell_NN surface_NN protein_NN with_IN a_DT mass_NN of_IN 130_CD kDa_NN in_IN a_DT divalent-cation-dependent_JJ manner_NN ._SENT However_RB ,_, transfection_NN of_IN CHO_NP cells_NNS with_IN cDNAs_NNS encoding_VBG human_JJ integrins_NNS alpha2_JJ ,_, alpha2beta1_JJ ,_, alpha3_JJ ,_, alpha5_JJ ,_, or_CC alphaV_NP did_VBD not_RB enhance_VB the_DT binding_NN of_IN Ad7_JJ nor_CC Ad11_JJ (_( data_NNS not_RB shown_VBN )_) ,_, indicating_VBG that_DT none_NN of_IN these_DT integrins_NNS corresponded_VBD to_TO sBAR_NN ._SENT Thus_RB ,_, the_DT role_NN of_IN CD46_NP during_IN Ad7_JJ binding_NN to_TO host_NN cells_NNS is_VBZ still_RB unclear_JJ ,_, and_CC we_PP cannot_MD exclude_VB the_DT possibility_NN that_IN sBAR_NN is_VBZ nonrelated_JJ and_CC nonassociated_JJ with_IN CD46_NP ._SENT Adenoviruses_NNS are_VBP frequently_RB used_VBN as_IN vectors_NNS in_IN gene_NN therapy_NN trials_NNS ,_, but_CC with_IN limited_JJ success_NN ._SENT In_IN most_JJS cases_NNS ,_, Ad5_NP is_VBZ used_VBN as_IN a_DT vector_NN backbone_NN ._SENT The_DT main_JJ disadvantages_NNS with_IN Ad5-based_JJ vectors_NNS appear_VBP to_TO be_VB low_JJ transduction_NN of_IN target_NN cells_NNS and_CC high_JJ preexisting_VBG immunity_NN ._SENT In_IN several_JJ cases_NNS ,_, species_NNS B:2_NP adenoviruses_NNS have_VBP been_VBN shown_VBN to_TO attach_VB to_TO host_VB cells_NNS and_CC deliver_VB genes_NNS much_RB more_RBR efficiently_RB than_IN other_JJ adenoviruses_NNS ,_, including_VBG Ad5_NP ._SENT Thus_RB ,_, we_PP believe_VBP that_IN the_DT identification_NN of_IN CD46_NP as_IN a_DT cellular_JJ receptor_NN for_IN these_DT adenoviruses_NNS widens_VBZ the_DT understanding_NN of_IN adenovirus_NN tropism_NN and_CC may_MD also_RB contribute_VB to_TO development_NN of_IN more_JJR effective_JJ adenovirus-based_JJ gene_NN therapy_NN vectors_NNS ._SENT Ad7_JJ and_CC Ad11_JJ virions_NNS exhibit_NN increased_VBD binding_VBG to_TO CHO-CD46_NP cells_NNS ._SENT Ad7_JJ and_CC Ad11_JJ virions_NNS exhibit_NN increased_VBD binding_VBG to_TO CHO-CD46_NP cells_NNS ._SENT The_DT ability_NN of_IN Ad5_NP (_( species_NN C_NP )_) (_( A_NP )_) ,_, Ad37_JJ (_( species_NN D_NP )_) (_( B_NP )_) ,_, Ad7_JJ (_( species_NN B:1_NP )_) (_( C_NP )_) ,_, and_CC Ad11_NP (_( species_NN B:2_NP )_) (_( D_NP )_) to_TO bind_VB to_TO CHO_NP cells_NNS transfected_VBN with_IN cDNAs_NNS encoding_VBG human_JJ CAR_NN ,_, CD55_NP (_( DAF_NP )_) ,_, and_CC CD46_NP (_( BC1_NP or_CC BC2_NP isoforms_NNS )_) was_VBD investigated_VBN as_IN described_VBN in_IN Materials_NPS and_CC Methods_NP ._SENT CD46_JJ expression_NN on_IN A549_NP cells_NNS and_CC CHO_NP cell_NN transfectants_NNS ._SENT CD46_JJ expression_NN on_IN A549_NP cells_NNS and_CC CHO_NP cell_NN transfectants_NNS ._SENT The_DT expression_NN of_IN CD46_NP on_IN A549_NP cells_NNS ,_, CHO_NP cells_NNS ,_, and_CC CHO_NP cells_NNS transfected_VBN with_IN cDNAs_NNS encoding_VBG the_DT BC1_NP and_CC BC2_NP isoforms_NNS of_IN CD46_NP was_VBD investigated_VBN by_IN using_VBG flow_NN cytometry_NN with_IN the_DT E4.3_NP monoclonal_NN anti-CD46_NN antibodies_NNS as_RB described_VBN in_IN Materials_NPS and_CC Methods_NP ._SENT Black_JJ and_CC white_JJ fields_NNS represent_VBP cells_NNS incubated_VBN in_IN the_DT absence_NN and_CC presence_NN of_IN anti-CD46_JJ antibodies_NNS ,_, respectively_RB ._SENT Anti-CD46_JJ antibodies_NNS inhibit_VBP binding_VBG of_IN species_NN B_NN adenoviruses_NNS to_TO CHO-BC1_NP and_CC A549_NP cells_NNS ._SENT Anti-CD46_JJ antibodies_NNS inhibit_VBP binding_VBG of_IN species_NN B_NN adenoviruses_NNS to_TO CHO-BC1_NP and_CC A549_NP cells_NNS ._SENT The_DT binding_NN of_IN Ad7_JJ (_( A_NP and_CC C_NP )_) and_CC Ad11_NP (_( B_NP and_CC D_NP )_) virions_NNS to_TO CHO-BC1_NP (_( A_NP and_CC B_NP )_) and_CC A549_NP (_( C_NP and_CC D_NP )_) preincubated_VBD with_IN or_CC without_IN (_( CTRL_NP )_) antibodies_NNS was_VBD performed_VBN as_IN described_VBN in_IN Materials_NPS and_CC Methods_NP ._SENT GB24_NP and_CC TRA-2-10_NP ,_, monoclonal_NN antibodies_NNS directed_VBN against_IN the_DT SCRs_NP 3/4_CD and_CC 1_CD ,_, respectively_RB ;_: Poly_NP ,_, rabbit_NN anti-human_NP CD46_NP polyclonal_JJ antiserum_NN ;_: RmcB_NP and_CC IF7_NP ,_, monoclonal_NN antibodies_NNS directed_VBN against_IN human_JJ CAR_NP and_CC CD55_NP ,_, respectively_RB ;_: rabbit-1_JJ and_CC rabbit-2_JJ ,_, serum_NN from_IN two_CD nonimmunized_JJ rabbits_NNS ._SENT CD46_NP promotes_VBZ infection_NN of_IN Ad11_NP in_IN CHO_NP cells_NNS ._SENT CD46_NP promotes_VBZ infection_NN of_IN Ad11_NP in_IN CHO_NP cells_NNS ._SENT (_( A_NP )_) Ad11_NP virions_NNS were_VBD allowed_VBN to_TO infect_VB CHO_NP cells_NNS or_CC CHO_NP cells_NNS transfected_VBN with_IN cDNAs_NNS encoding_VBG the_DT BC1_NP or_CC BC2_NP isoforms_NNS of_IN human_JJ CD46_NP ,_, as_RB described_VBN in_IN Materials_NPS and_CC Methods_NP ._SENT (_( B_LS )_) CHO-BC1_JJ cells_NNS were_VBD preincubated_VBN with_IN rabbit_NN anti-CD46-serum_NN before_IN infection_NN with_IN Ad11_JJ virions_NNS ._SENT At_IN 44_CD h_NN after_IN infection_NN ,_, the_DT cells_NNS were_VBD fixed_VBN ,_, stained_VBN ,_, and_CC visualized_VBN by_IN using_VBG a_DT fluorescent_JJ microscope_NN as_IN described_VBN in_IN Materials_NPS and_CC Methods_NP ._SENT Ca2+_NP or_CC Mn2+_NP ions_NNS promote_VBP binding_VBG of_IN Ad7_JJ virions_NNS to_TO CHO_NP and_CC CHO-BC1_NP cells_NNS ._SENT Ca2+_NP or_CC Mn2+_NP ions_NNS promote_VBP binding_VBG of_IN Ad7_JJ virions_NNS to_TO CHO_NP and_CC CHO-BC1_NP cells_NNS ._SENT The_DT ability_NN of_IN 35S-labeled_JJ virions_NNS to_TO bind_VB to_TO EDTA-pretreated_NP CHO-BC1_NP (_( Ad11_NP [_SYM A_NP ]_SYM and_CC Ad7_NP [_SYM B_NP ]_SYM )_) or_CC CHO_NP (_( Ad7_NP [_SYM C_NP ]_SYM )_) cells_NNS in_IN the_DT presence_NN of_IN Ca2+_NP ,_, Mn2+_NP ,_, or_CC Mg2+_NP and_CC either_RB with_IN or_CC without_IN rabbit_NN anti-CD46_NN serum_NN ,_, was_VBD investigated_VBN as_IN described_VBN in_IN Materials_NPS and_CC Methods_NP ._SENT Trypsination_NN of_IN CHO-BC1_JJ cells_NNS inhibits_VBZ the_DT binding_NN of_IN Ad7_JJ but_CC enhances_VBZ the_DT binding_NN of_IN Ad11_NP ._SENT Trypsination_NN of_IN CHO-BC1_JJ cells_NNS inhibits_VBZ the_DT binding_NN of_IN Ad7_JJ but_CC enhances_VBZ the_DT binding_NN of_IN Ad11_NP ._SENT The_DT ability_NN of_IN Ad7_JJ and_CC Ad11_JJ virions_NNS to_TO bind_VB to_TO CHO-BC1_JJ cells_NNS either_CC pretreated_VBN with_IN trypsin_NN or_CC left_VBN untreated_JJ was_VBD investigated_VBN as_IN described_VBN in_IN Materials_NPS and_CC Methods_NP ._SENT Ad11_JJ fiber_NN knobs_NNS block_VB the_DT binding_NN of_IN Ad11_JJ virions_NNS to_TO A549_NP and_CC CHO-BC1_NP cells_NNS ._SENT Ad11_JJ fiber_NN knobs_NNS block_VB the_DT binding_NN of_IN Ad11_JJ virions_NNS to_TO A549_NP and_CC CHO-BC1_NP cells_NNS ._SENT Binding_VBG of_IN Ad11_JJ virions_NNS to_TO A549_NP preincubated_VBN with_IN homologous_JJ fiber_NN knobs_NNS or_CC binding_VBG to_TO CHO-BC1_JJ cells_NNS preincubated_VBN with_IN homologous_JJ fiber_NN knobs_NNS or_CC fiber_NN knobs_NNS from_IN Ad5_NP or_CC Ad7_NP was_VBD investigated_VBN as_IN described_VBN in_IN Materials_NPS and_CC Methods_NP ._SENT 